{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:04:39Z","timestamp":1789477479272,"version":"build-2803163510"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiomes"],"abstract":"<jats:p>Menopause is accompanied by profound hormonal changes that alter the composition and function of the gut microbiome, potentially influencing microbial drug metabolism and therapeutic response. At the same time, medication use increases substantially during midlife, creating a dynamic bidirectional relationship in which medications modify the gut microbiome while microbiome remodeling may influence medication efficacy, toxicity, and interindividual differences in drug response. This narrative review examines current evidence linking menopause-associated changes in the gut microbiome with medication response and explores the biological mechanisms that may underlie these interactions. The review summarizes microbiome-mediated pathways including microbial \u03b2-glucuronidase activity, direct microbial drug metabolism, altered bile acid metabolism, microbial metabolite signaling, and changes in intestinal barrier function and immune regulation that may influence pharmacokinetics and pharmacodynamics. Although direct evidence connecting menopause-associated microbiome remodeling with altered drug response remains limited, substantial evidence supports independent effects of menopause on the gut microbiome and of the gut microbiome on drug metabolism. Together, these findings provide a conceptual framework for understanding how menopause-associated microbial changes may contribute to variability in pharmacotherapy and highlight important priorities for future research, including incorporation of menopausal status into pharmacokinetic studies and clinical trials to advance microbiome-informed precision medicine for women.<\/jats:p>","DOI":"10.3389\/frmbi.2026.1953547","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:03:10Z","timestamp":1789473790000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Menopause-associated gut microbiome remodeling and pharmacomicrobiomics: emerging mechanisms influencing drug response"],"prefix":"10.3389","volume":"5","author":[{"given":"Susanne B.","family":"Haga","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine","place":["Durham, NC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","article-title":"Estrogen-gut microbiome axis: physiological and clinical implications","volume":"103","author":"Baker","year":"2017","journal-title":"Maturitas"},{"key":"B2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5888\/pcd17.200130","article-title":"Prevalence of multiple chronic conditions among US adult","volume":"17","author":"Boersma","year":"2020","journal-title":"Prev. Chronic. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1172\/jci72335","article-title":"Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics","volume":"124","author":"Carmody","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/gerona\/glv013","article-title":"Polypharmacy among adults aged 65 years and older in the United States: 1988-2010","volume":"70","author":"Charlesworth","year":"2015","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41467-017-00901-0","article-title":"The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases","volume":"8","author":"Chen","year":"2017","journal-title":"Nat. Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/biomedicines12010221","article-title":"Microbiota implications in endocrine-related diseases: from development to novel therapeutic approaches","volume":"12","author":"Clemente-Su\u00e1rez","year":"2024","journal-title":"Biomedicines"},{"key":"B9","doi-asserted-by":"publisher","first-page":"16372","DOI":"10.1038\/s41598-018-34678-z","article-title":"\u03b2-Glucuronidases of opportunistic bacteria are the major contributors to xenobiotic-induced toxicity in the gut","volume":"8","author":"Dashnyam","year":"2018","journal-title":"Sci. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jad.2016.07.040","article-title":"Depression during the perimenopause: a meta-analysis","volume":"206","author":"de Kruif","year":"2016","journal-title":"J. Affect. Disord."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101986R","article-title":"Pharmacomicrobiomics: influence of gut microbiota on drug and xenobiotic metabolism","volume":"36","author":"Dikeocha","year":"2022","journal-title":"FASEB J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s40168-025-02142-6","article-title":"Microbiome-derived reactivation of mycophenolate explains variations in enterohepatic recirculation in kidney transplant recipients","volume":"13","author":"Drevland","year":"2025","journal-title":"Microbiome"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2026.105471","article-title":"Estrobolome and the endocrine-microbiome axis in breast and endometrial carcinogenesis","volume":"225","author":"El-Sehrawy","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"18586","DOI":"10.1074\/jbc.RA119.010950","article-title":"Gut microbial \u03b2-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens","volume":"294","author":"Ervin","year":"2019","journal-title":"J. Biol. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1210\/clinem\/dgz196","article-title":"Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS\/MS","volume":"105","author":"Frederiksen","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"103316","DOI":"10.1016\/j.drudis.2022.07.001","article-title":"The role of gut microbial \u03b2-glucuronidase in drug disposition and development","volume":"27","author":"Gao","year":"2022","journal-title":"Drug Discov. Today"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/cpt.70066","article-title":"Pharmacomicrobiomics","volume":"118","author":"Gronich","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1126\/science.1235872","article-title":"Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta","volume":"341","author":"Haiser","year":"2013","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2236749","article-title":"Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism","volume":"15","author":"Hu","year":"2023","journal-title":"Gut. Microbes"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.3390\/jcm12227058","article-title":"Menopause predisposes women to increased risk of cardiovascular disease","volume":"12","author":"Kami\u0144ska","year":"2023","journal-title":"J. Clin. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","article-title":"Gut microbial metabolites as multi-kingdom intermediates","volume":"19","author":"Krautkramer","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1002\/jcb.26638","article-title":"Mechanistic and structural insight into promiscuity based metabolism of cardiac drug digoxin by gut microbial enzyme","volume":"119","author":"Kumar","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202300688","article-title":"From gut to hormones: unraveling the role of gut microbiota in (phyto)estrogen modulation in health and disease","volume":"68","author":"Kumari","year":"2024","journal-title":"Mol. Nutr. Food Res."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw029","article-title":"The intestinal microbiome and estrogen receptor-positive female breast cancer","volume":"108","author":"Kwa","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"B26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ijc.35427","article-title":"The estrobolome: estrogen-metabolizing pathways of the gut microbiome and their relation to breast cancer","volume":"157","author":"Larnder","year":"2025","journal-title":"Int. J. Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1517\/17425255.2016.1121234","article-title":"The influence of gut microbiota on drug metabolism and toxicity","volume":"12","author":"Li","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6323","article-title":"Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism","volume":"364","author":"Maini Rekdal","year":"2019","journal-title":"Science"},{"key":"B30","first-page":"1","article-title":"Prescription drug use in the United States 2015-2016","volume":"334","author":"Martin","year":"2019","journal-title":"Natl. Health Nutr. Examination. Survey."},{"key":"B31","first-page":"2182","article-title":"Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)","volume":"7","author":"Mathijssen","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.maturitas.2022.08.008","article-title":"Eligibility criteria for menopausal hormone therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group","volume":"166","author":"Mendoza","year":"2022","journal-title":"Maturitas"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70778","article-title":"The prevalence of polypharmacy and the contribution of age, period, and cohort effects in Sweden from 2006 to 2020","volume":"8","author":"Miao","year":"2025","journal-title":"Health Sci. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-024-00914-3","article-title":"The changing metabolic landscape of bile acids - keys to metabolism and immune regulation","volume":"21","author":"Mohanty","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-026-01074-9","article-title":"Beyond estrobolome 1.0: unraveling endocrine-microbiome axis as a driver and therapeutic target in hormone-driven cancers","author":"Mou","year":"2026","journal-title":"NPJ Biofilms. Microbiomes"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.1223813","article-title":"Host-gut microbiota metabolic interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s12272-017-0986-y","article-title":"Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs","volume":"40","author":"Noh","year":"2017","journal-title":"Arch. Pharm. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00248-022-02081-x","article-title":"Human gut microbiota and drug metabolism","volume":"86","author":"Pant","year":"2023","journal-title":"Microb. Ecol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/diagnostics13061193","article-title":"Menopausal changes in the microbiome-a review focused on the genitourinary microbiome","volume":"13","author":"Park","year":"2023","journal-title":"Diagnostics. (Basel)."},{"key":"B40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4103\/jmh.jmh_75_25","article-title":"Estrogen and metabolism: navigating hormonal transitions from perimenopause to postmenopause","volume":"16","author":"Patel","year":"2025","journal-title":"J. Midlife. Health"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01283","article-title":"Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles","volume":"9","author":"Pavlovi\u0107","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/s0022-3565(25)29238-2","article-title":"The role of intestinal bacteria in the metabolism of salicylazosulfapyridine","volume":"181","author":"Peppercorn","year":"1972","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00273-22","article-title":"Menopause is associated with an altered gut microbiome and estrobolome, with implications for adverse cardiometabolic risk in the Hispanic Community Health Study\/Study of Latinos","volume":"7","author":"Peters","year":"2022","journal-title":"mSystems"},{"key":"B44","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.chom.2011.10.003","article-title":"Microbiome and Malignancy","volume":"10","author":"Plottel","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B45","doi-asserted-by":"publisher","first-page":"s15","DOI":"10.5604\/01.3001.0010.5494","article-title":"The role of the gut microbiota in bile acid metabolism","volume":"16","author":"Ram\u00edrez-P\u00e9rez","year":"2017","journal-title":"Ann. Hepatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41575-024-00896-2","article-title":"Another renaissance for bile acid gastrointestinal microbiology","volume":"21","author":"Ridlon","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"458","DOI":"10.5114\/aoms\/157308","article-title":"Menopause and women's cardiovascular health: is it really an obvious relationship","volume":"19","author":"Ryczkowska","year":"2023","journal-title":"Arch. Med. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgaa764","article-title":"The menopause transition: signs, symptoms, and management options","volume":"106","author":"Santoro","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1780806","article-title":"The impact of estrogen status on the gut microbiome: a systematic review and meta-analysis","volume":"17","author":"Saravinovska","year":"2026","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1607899","article-title":"Bile acids affect intestinal barrier function through FXR and TGR5","volume":"12","author":"Song","year":"2025","journal-title":"Front. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.07.009","article-title":"The gastrointestinal microbiota as a site for the biotransformation of drugs","volume":"363","author":"Sousa","year":"2008","journal-title":"Int. J. Pharm."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118991","article-title":"Co-prescription trends in a large cohort of subjects predict substantial drug-drug interactions","volume":"10","author":"Sutherland","year":"2015","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/gme.0000000000002028","article-title":"The 2022 hormone therapy position statement of The North American Menopause Society","volume":"29","year":"2022","journal-title":"Menopause"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3892\/or.10.6.1977","article-title":"The relative contributions of carboxylesterase and beta-glucuronidase in the formation of SN-38 in human colorectal tumours","volume":"10","author":"Tobin","year":"2003","journal-title":"Oncol. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"22086","DOI":"10.1038\/s41598-022-26528-w","article-title":"Analysis of the oral microbiome during hormonal cycle and its alterations in menopausal women: the \"AMICA\" project","volume":"12","author":"Tramice","year":"2022","journal-title":"Sci. Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1186\/s41256-023-00311-4","article-title":"Prevalence and trends of polypharmacy in U.S. adults 1999-2018","volume":"8","author":"Wang","year":"2023","journal-title":"Glob. Health Res. Policy"},{"key":"B58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13099-023-00553-0","article-title":"Gut microbiota signatures and fecal metabolites in postmenopausal women with osteoporosis","volume":"15","author":"Wang","year":"2023","journal-title":"Gut. Pathog."},{"key":"B59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tim.2017.07.008","article-title":"Women and their microbes: The unexpected friendship","volume":"26","author":"Younes","year":"2018","journal-title":"Trends Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jgg.2024.11.010","article-title":"Deciphering the influence of gut and oral microbiomes on menopause for healthy aging","volume":"52","author":"Yu","year":"2025","journal-title":"J. Genet. Genomics"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2025.10011","article-title":"Mechanism of microbiota-gut-brain in perimenopausal depression: An inflammatory perspective","volume":"27","author":"Yu","year":"2025","journal-title":"Expert Rev. Mol. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/03602532.2018.1497647","article-title":"Gut microbiota modulates drug pharmacokinetics","volume":"50","author":"Zhang","year":"2018","journal-title":"Drug Metab. Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","article-title":"Drug-microbiota interactions: An emerging priority for precision medicine","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"}],"container-title":["Frontiers in Microbiomes"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frmbi.2026.1953547\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:03:12Z","timestamp":1789473792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frmbi.2026.1953547\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":64,"alternative-id":["10.3389\/frmbi.2026.1953547"],"URL":"https:\/\/doi.org\/10.3389\/frmbi.2026.1953547","relation":{},"ISSN":["2813-4338"],"issn-type":[{"value":"2813-4338","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1953547"}}